Search

everythinglearnresearchcommunity

for

Search:↓

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Different anti-androgen medications can help treat excessive hair growth, but the right choice depends on accurate diagnosis.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

The cause of atypical Cushing's syndrome in dogs, possibly linked to sex hormones, is not yet proven.

Treatments for common hair loss include minoxidil, finasteride, and hair transplantation.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

Treating excessive hair in women requires a holistic approach, including medical, aesthetic, and emotional support.

The conclusion is that a thorough approach is needed to diagnose and manage hyperandrogenism in teenage girls, recognizing its major psychological and health effects.

Certain drugs change freshwater snail shells to a "banana" shape.

Adult acne severity is influenced by stress, skin sensitivity, makeup, stopping oral contraceptives, and requires female-specific treatment guidelines.

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

The document concludes that diagnosing PCOS requires a thorough approach, considering various symptoms and risks, and calls for improved methods to identify PCOS types and prevent diabetes.

New acne treatments include combination creams, advanced retinoids, and light therapies, focusing on safety and patient adherence.

Ethinylestradiol/chlormadinone acetate may be an effective and well-tolerated treatment for skin conditions caused by excess androgens.

The paper suggests that France's suspension of Diane-35 was hasty and could cause treatment issues and unintended pregnancies, recommending a re-evaluation and better patient information.

Women using hair relaxers with alopecia had lower zinc levels, suggesting zinc deficiency might contribute to hair loss.

PCOS treatment focuses on lifestyle changes and specific medications to manage symptoms and complications.

PCOS often causes skin issues like excess hair, acne, and hair loss, needing early treatment.

New testosterone analogs show promise for male contraception with better activity and potentially fewer side effects.

Women with irregular periods should be checked for PCOS and treated early to prevent complications, with birth control pills helping to manage symptoms.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

Skin symptoms can indicate endocrine disorders and have various treatments.

Eating disorders can cause various hair problems, and while hair loss in these disorders is linked to metabolic syndrome, treatment focuses on specific medications and lifestyle changes for the syndrome.

The document concludes that early diagnosis and treatment of PCOS in teenagers is important for managing symptoms and preventing long-term health problems.

Hirsutism is often caused by high male hormone levels and can be treated with lifestyle changes and medications.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.